Trial Profile
Randomized, Single-Dose, Two-Way Crossover, Open-Label Study to Evaluate Pharmacokinetics of Bucretis Orodispersible Film 1.0 mg and Baraclude Tablet 1.0 mg in Healthy Thai Subjects under Fasting Conditions
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Jun 2017
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Abbott Healthcare Products
- 06 Jun 2017 New trial record